Nalu Medical

Country:
USA
Founding year:
2017

Nalu Medical is a neurotechnology company developing an implantable neuromodulation platform designed to treat chronic pain and related neurological conditions. The company focuses on rethinking the architecture of implanted stimulators by separating stimulation hardware from power and control components.

Its system uses an ultra-small implant paired with an external wearable power source, eliminating the need for an implanted battery. This design enables high-output stimulation while reducing implant size, surgical burden, and replacement procedures, and supports personalized programming through external controllers.

Nalu Medical’s technology is intended for clinical use in pain management and neuromodulation therapy settings. The company positions its platform as next-generation implantable infrastructure that improves patient experience and long-term therapy delivery compared with conventional fully implanted stimulators.

Neuromodulation
Therapeutics
Clinical Workflows

Neurofounders Insights

Modality:
Nerve stimulator
Form Factor:
Implant
Interface Depth:
Minimally invasive
Indication:
Pain/migraine
Target user:
Patients
Regulatory stage:
FDA cleared (501k)

Acquired

Nalu Medical is one of the more commercially advanced miniaturized neuromodulation companies, using a battery-free implant architecture to reduce implant burden in chronic pain treatment. Its FDA-cleared status and acquisition support make it a credible procedural innovator in peripheral neuromodulation.

Related companies

Articles featuring

Nalu Medical

No articles yet!

Press releases

No press releases published yet.